These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1745714)

  • 1. Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol.
    Mittman SM; Geyer MA
    Psychopharmacology (Berl); 1991; 105(1):69-76. PubMed ID: 1745714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5HT-2 mediation of acute behavioral effects of hallucinogens in rats.
    Wing LL; Tapson GS; Geyer MA
    Psychopharmacology (Berl); 1990; 100(3):417-25. PubMed ID: 2138338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens.
    Mittman SM; Geyer MA
    Psychopharmacology (Berl); 1989; 98(3):321-9. PubMed ID: 2501811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
    Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
    Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors.
    Krebs-Thomson K; Paulus MP; Geyer MA
    Neuropsychopharmacology; 1998 May; 18(5):339-51. PubMed ID: 9536447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats.
    Krebs KM; Geyer MA
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):429-37. PubMed ID: 7862855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of DOM and DMT in a proposed animal model of hallucinogenic activity.
    Adams LM; Geyer MA
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):121-32. PubMed ID: 3858911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide.
    Adams LM; Geyer MA
    Pharmacol Biochem Behav; 1985 Sep; 23(3):461-8. PubMed ID: 4048241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LSD-induced alterations of locomotor patterns and exploration in rats.
    Adams LM; Geyer MA
    Psychopharmacology (Berl); 1982; 77(2):179-85. PubMed ID: 6812137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
    Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
    Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
    Marona-Lewicka D; Thisted RA; Nichols DE
    Psychopharmacology (Berl); 2005 Jul; 180(3):427-35. PubMed ID: 15723230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    Sanders-Bush E; Burris KD; Knoth K
    J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI.
    Marona-Lewicka D; Chemel BR; Nichols DE
    Psychopharmacology (Berl); 2009 Apr; 203(2):265-77. PubMed ID: 18604600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic mediation of the anxiolytic effect of intracerebrally injected propranolol measured in the elevated plus-maze.
    Audi EA; de-Oliveira CE; Graeff FG
    Braz J Med Biol Res; 1989; 22(6):699-701. PubMed ID: 2515907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.